Norway

Study populations 

Norway, in 2016, had an estimated population of 5.2m, with 17% being over the age of 65 years. By 2050, it is expected that the population will increase to 6.5m and one in four people (24%) will be aged 65 years and older (1.5m).

Alongside the ageing population, diabetes prevalence is increasing – with the most recent statistics reporting 289,600 people living with the condition and an estimated 109,300 undiagnosed cases. Of note, Norway is ranked 4th in the world for the number of new cases of type 1 diabetes for people under 15 years of age, at an estimated 32.5 cases per 100,000 population per year.

Report & Infographic 

Cover page for Norway Study Report. For accessible PDF version of full report click the image.
Info-graphic containing overview of findings. For an accessible PDF please click the image.

Availability of DR patient education materials in health care providers’ offices

20% Sufficient information available, 20% Information not sufficient, 60% No written information available, 0% Don’t know
(All providers n=5)
Sufficient information available Information not sufficient No written information available Don’t know

Percentage of adults with diabetes who have completed an eye exam

75.7% Have had an eye exam, 24.3% Never had an eye exam
(Opthamologists n=70)
Have had an eye exam
Never had an eye exam
 

Complications adults with diabetes were most concerned about

45.7% Vision loss, 8.6% Amputation, 5.7% Kidney disease
(Adults with diabetes n=70)
Vision loss Amputation Kidney disease

Frequency of discussions about eye complications with health care providers

7.1% Every visit, 12.9% Multiple times per year, 37.1% Once a year, 11.4% When symptoms arise, 24.3% Never
(Adults with diabetes n=70)
Every visit Multiple times per year Once a year When symptoms arise Never
banner-join-community

The DR Barometer Community is a growing multidisciplinary network of thought leaders and organizations who are working together to address gaps in diabetes patient care. Join today to help improve vision health outcomes among people living with diabetes.